SCHEMBL5755090

SCHEMBL5755090

COC(=O)C(S)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7640960 0.80 SMN1; SMN2 (0.48)
SCHEMBL2035273 0.80 SMN1; SMN2 (0.48)
SCHEMBL10329462 0.80 SMN1; SMN2 (0.48)
SCHEMBL932508 0.78
SCHEMBL2598147 0.78
SCHEMBL29064781 0.75
SCHEMBL6698356 0.75
SCHEMBL8170904 0.75
SCHEMBL27487722 0.75
Hydrochloric Acid SCHEMBL6942925 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1989008835-A1 THIOACYLATION PEPTIDE SEQUENCING WITH ACYLATION OF THIAZOLINES BIO-AFFINITY SYSTEMS, INC. (US) 1989-09-21 WO claimed
US-4861726-A Method of thioacylation peptide sequencing with acylation of thiazoloinones BIO-AFFINITY SYSTEMS, INC. (US) 1989-08-29 US claimed
JP-62127330-A None JP disclosed
CN-121248501-A Preparation method of luminescent compound 苏州亚科科技股份有限公司 2026-01-02 CN disclosed
EP-1446403-B1 ARYL SUBSTITUTED OXAZOLIDINONES WITH ANTIBACTERIAL ACTIVITY ASTRAZENECA AB (SE) 2006-04-12 EP disclosed
US-20050043374-A1 Aryl substituted oxazolidinones with antibacterial activity ASTRAZENECA AB (SE) 2005-02-24 US disclosed
EP-1446403-A1 ARYL SUBSTITUTED OXAZOLIDINONES WITH ANTIBACTERIAL ACTIVITY AstraZeneca AB (SE) 2004-08-18 EP disclosed
WO-2003035648-A1 ARYL SUBSTITUTED OXAZOLIDINONES WITH ANTIBACTERIAL ACTIVITY ASTRAZENECA AB (SE) 2003-05-01 WO disclosed
CN-1255044-A Orally active fraction of momordica charantia, active peptides thereof, and their use for treating diabetes KARIKS THERAPEUTIC CORP (US) 2000-05-31 CN disclosed
EP-0907653-A1 PROCESS FOR THE PREPARATION OF PENAM AND PENEM DERIVATIVES ZENECA LIMITED (GB) 1999-04-14 EP disclosed
WO-1998000429-A1 PROCESS FOR THE PREPARATION OF PENAM AND PENEM DERIVATIVES ZENECA LIMITED (GB) 1998-01-08 WO disclosed
EP-0144154-B1 PROTEIN CONJUGATES OF PENICILLOIC ACID, THEIR PREPARATION AND USE SYNTEX (U.S.A.) INC. (US) 1989-07-12 EP disclosed
JP-S62127330-A RUBBER COMPOSITION FOR TIRE TREAD ASAHI CHEM IND CO LTD 1987-06-09 JP disclosed
US-4596768-A Combining assay sample, enzyme-penicilloic acid conjugate and support containing antibodies, separating support, determining enzyme activity to indicate presence of penicilloic acid SYNTEX (U.S.A.) INC. (US) 1986-06-24 US disclosed
EP-0177344-A2 Serum pretreatment for tricyclic antidepressant drug assays and kit therefor SYNTEX (U.S.A.) INC. (US) 1986-04-09 EP disclosed
US-4551275-A ANTIBODIES SYNTEX (U.S.A.) INC. (US) 1985-11-05 US disclosed
EP-0144154-A1 Protein conjugates of penicilloic acid, their preparation and use SYNTEX (U.S.A.) INC. (US) 1985-06-12 EP disclosed
US-4328311-A USEFUL IN IMMUNOASSAY SYVA COMPANY (US) 1982-05-04 US disclosed
US-4220722-A ACYLATION, AMIDATION, SULFIDING SYVA COMPANY (US) 1980-09-02 US disclosed
US-4182866-A CEPHALOSPORINS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1980-01-08 US disclosed